Hangzhou Tian-Mu-Shan Pharmaceutical Hits Day Low Amid Price Pressure at CNY 19.10

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd. experienced a significant decline today, with the stock dropping by 9.99% on March 23, 2026. The stock reached an intraday low of CNY 19.10, reflecting a challenging trading session for the small-cap pharmaceutical company. In terms of performance metrics, Hangzhou Tian-Mu-Shan has shown a year-to-date increase of 10.34%, contrasting with the China Shanghai Composite's decline of 3.92%. However, over the past week, the stock has decreased by 10.16%, while its one-month performance stands at a decline of 6.46%. Notably, the company has demonstrated strong annual growth of 76.85% over the past year, significantly outperforming the broader market index, which recorded a gain of only 13.33%. Despite these positive yearly figures, the company's long-term fundamentals indicate areas of concern, including a modest average Return on Capital Employed (ROCE) of 5.37% and a high Debt to Equity ratio of 2.33. These factors may contribute to the stock's current volatility and market performance.